Xiaomo Biotech is an expert on RNA biosynthesis. Our green biomanufacturing technology produces highly potent, specific, and cost-effective siRNAs (to kilograms) for various RNAi applications including gene knockdown in mammalian cells, high-throughput RNAi screen and RNAi pesticide. Xiaomo is committed to developing cutting-edge biotech products based on RNA interference (RNAi), a natural process which uses small interfering RNAs (siRNAs) to silence target genes in a precise manner. Xiaomo possesses a revolutionary RNAi platform technology known as the ‘prokaryotic siRNA’ (pro-siRNA) technology. The pro-siRNA technology uses bacteria as siRNA ‘factory’ instead of using chemical synthesis. This unique biomanufacturing method enables cost-effective and environmentally friendly production of highly effective siRNAs on a massive scale. Xiaomo has the capacity to produce siRNAs in gram to kilogram scales using bacterial fermentation. Xiaomo has also developed a customized high-throughput RNAi screen technique to identify potential therapeutic target genes in a disease, that could lead to the development of novel RNAi therapeutics. Currently, Xiaomo is offering various biomanufactured siRNA and RNAi library products to the R&D market. Xiaomo’s R&D efforts focus on developing first-in-class RNA pesticides for important crop pests including fungi, insects and nematodes. The ultimate goal of Xiaomo is to provide effective and affordable RNAi solutions for improving both human health and agricultural health. Xiaomo Biotech (www.xiaomobio.com) was founded at Hong Kong Science Park in 2019. We have recently established R&D and production sites in Shanghai Zhangjiang and Suzhou Kunshan China.
WT Faba Biocatalyst LLP
WT Faba Catalyst: Bridging Science and Business in Life Sciences WT Faba Catalyst, a pioneering initiative of the ‘Whale Tank FABA Life Science Fund’, is redefining how Indian innovation in life sciences reaches global markets. Born from the vision of seasoned veterans and mission-driven leaders, it provides not just capital—but clarity, confidence, and capability—to life science startups poised to transform human health, agriculture, and nutrition. With ‘strategic partnerships’ that already include Revelations Biotech’, ‘ATGC Biotech’, and ‘Utopia Therapeutics’, Whale Tank has become a cornerstone of support for startups navigating the demanding path from the lab bench to the marketplace. **Our Origin Story: Built by Experts, For Innovators** Whale Tank was founded by a group of **industry veterans** with a shared mission: **to resolve the systemic challenges faced by deep-science startups** in India and the global South. From their work in pharma, agritech, biotech, and venture capital, these leaders understood a core reality—**innovation alone isn’t enough**. Scientific breakthroughs often stall due to fragmented business planning, unclear market access, and limited investor guidance. To change this narrative, Whale Tank was established as a **science-first catalyst** with business-savvy DNA, offering tailored support to help life sciences ventures scale impact and unlock commercial potential. — ### **Strategic Partnerships that Amplify Innovation** Whale Tank doesn’t just fund ideas—it backs missions. Our growing portfolio features strategic collaborations with: #### **Revelations Biotech** An innovative force in **natural sweeteners and prebiotics**, Revelations is redefining food and nutrition science with cutting-edge products like **Fructooligosaccharides (FOS)**, **Brazzein**, and **Allulose**. Whale Tank invested $2 million in this high-growth venture, facilitating: – Global partnerships with **Kellogg’s**, **PepsiCo**, **Nestlé**, **Britannia**, and **Unilever** – Scale-up of production infrastructure (fermentation and spray-drying facilities) – Market penetration across **North America**, **Europe**, and **Asia-Pacific** Revelations reflects Whale Tank’s belief that **science-driven startups can reshape public health, when supported with strategic capital and mentorship**. #### **ATGC Biotech** As a biotechnology pioneer in **sustainable agriculture and pest management**, ATGC has developed eco-friendly technologies that improve crop yields while minimizing environmental impact. Under the leadership of **Dr. Markandeya Gorantla** and **Rolando Alegria**, ATGC: – Specializes in bio-rational solutions using behavioral ecology using pheromone based mating disruption technology – Has filed multiple patents and gained regulatory approvals – Has scaled distribution through private sector and public procurement models Whale Tank and ATGC share a common DNA: commitment to **science-backed sustainability** and **farm-to-fork innovation**. #### **Utopia Therapeutics** Founded by **Dr. Uday Saxena**, Utopia is a drug discovery and therapeutics startup with a focus on **neurodegenerative and metabolic disorders**. Utopia’s leadership—rooted in big pharma —guides startups in navigating clinical validation, regulatory frameworks. Whale Tank’s synergy with Utopia provides its portfolio companies with strategic insights into **drug development lifecycles**, **FDA compliance**, and **venture pathways. — ### **Mission-Driven Investment Philosophy** At its core, **Whale Tank is a catalyst, not just a fund**. Our mission is to: – **Fuel Innovation** through strategic, milestone-based capital – **Bridge Science and Business** with real-world execution models – **Accelerate Commercialization** across agriculture, biotech, diagnostics, and therapeutics – **Empower Indian Science** by building platforms for global impact We understand that scientific excellence must be matched with **business discipline** and **market readiness**—so we provide both. — ### **Our Values: The Whale Tank Ethos** Our approach is guided by unwavering principles that reflect our commitment to lasting impact: #### Integrity as a Foundation of Trust We uphold the highest standards of transparency and ethical governance, ensuring alignment between founders, investors, and stakeholders. #### Collaboration for Greater Innovation We believe that breakthrough ideas flourish in collaborative ecosystems. Whale Tank connects innovators with world-class mentors, global partners, and technical experts to foster innovation at scale. #### Commitment to Continuous Improvement The life sciences landscape evolves fast—and so do we. From regulatory updates to tech advancements, we equip our portfolio with the latest tools to stay competitive and compliant. — ### **Our Differentiators: The Whale Tank Advantage** Whale Tank delivers a full-spectrum support model that integrates: | Service | Description | |——–|————-| | **Visionary Capital** | Flexible seed and Series A funding, aligned to product-market readiness | | **Mentorship Network** | Access to 50+ domain experts in biotech, drug development, clinical trials, and regulatory science | | **Business Alchemy** | Go-to-market, licensing, pricing, and distribution support | | **IP & Legal Advisory** | End-to-end guidance on patents, exclusivity, and data rights | | **Infrastructure Scaling** | Support for facility design, tech transfer, and manufacturing scale-up | | **Exit Strategy Navigation** | IPO prep, M&A, and secondary share sale pathways | This framework has empowered startups to **reduce time-to-market**, **attract global partners**, and **build sustainable revenue models**. — ### **Governance, Structure & Investor Value** ### **Impact Snapshot: Delivering Results that Matter** Beyond numbers, our true impact is in lives touched, diseases addressed, and ecosystems enhanced. Whether it’s **healthy nutrition**, **sustainable farming**, or **precision medicine**, Whale Tank empowers science that serves society. — ### **Vision for the Future: Scaling Science for Global Good** Whale Tank is now building a **pipeline of next-gen ventures** across: – **Synthetic Biology** – **Microbiome Therapeutics** – **Agricultural Biocontrols** – **Climate-Resilient Crop Technologies** – **Affordable Diagnostics and Functional Foods** Our goal is to create **India’s first science-forward unicorns** that are not just financially successful—but mission-aligned and globally relevant. — ### **Join the Movement: Let’s Build the Future of Life Sciences** We invite researchers, entrepreneurs, and investors to partner with us. Whether you’re developing the next sugar alternative, breakthrough therapy, or agricultural bioinnovation—**Whale Tank will help you get there.** For partnerships and investment inquiries, contact: **Dr. Jagadeesh Gandla** Chief Operating Officer, Whale Tank FABA Life Science Fund **info@whaletank.in** — **WT Faba Catalyst isn’t just a fund. It’s a movement.** A movement to **empower ideas**, **bridge discovery with delivery**, and **build India’s life sciences future**—one transformative startup at a time. Let’s catalyze the change.
Viruj Group
Viruj Group was established in 2014 by a group of young & experienced professionals with the specific objective to develop & produce complex, small to large volume, technology driven Intermediates/ API at competitive prices, thus providing the critical India advantage for a CRO/ NCE Molecules across the world. We are a partner for various Innovator companies to supply High Quality API’s /Intermediates & Fine chemicals at competitive prices Complying with Regulatory Requirements. Our Experienced R&D team – well qualified & equipped to develop most complex Intermediates/ APIs and expertise to handle wide range of chemical reactions. Manufacturing capabilities ranging from gram level to multiple ton lots. Strong Intellectual Property Management and Regulatory back up & Absolute assurance of best quality APIs. Expertise in the development of novel, non-infringing and cost-effective API’s Speed to market for customers and support the NCE / Dossier by time bound development. Timely delivery and prompt response to all queries of the customers CRO/CDMO – We intend to take up any projects in this area working closely with you team for small or big enquiries, we have a dedicated team working in this area. Flow Chemistry – Our process lab is established with a motto to make API / Intermediates and Fine Chemicals in Flow chemistry mode as far as the molecule permits, we have established few global business and making R&D/ Pilot scale modules and converting existing batch chemistry to flow chemistry way. We are ready to take up projects for any commercial scale products on Pharma/ Agro/Fine Chemicals space.
Vipragen Biosciences Private Limited
Vipragen Biosciences Pvt. Ltd. is a CRO certified by NGCMA for OECD-GLP to carry out safety studies for regulatory submissions. Additionally, the laboratory has been certified by AAALAC, NABL, and DCGI to support discovery research. Vipragen has deep scientific and research knowledge with a combined experience of over 150 years of the senior leadership team in areas such as General Toxicology, Reproductive Toxicology, Genetic Toxicology, Pharmacology, Analytical Chemistry, Bioanalytical and ADME. | Vipragen Biosciences Pvt. Ltd. is a globally recognized Contract Research Organization(CRO) which has been in the industry for more than a decade now and specializing in delivering comprehensive pre-clinical services to Global Drug Discovery companies. We are OECD-GLP certified and AAALAC accredited laboratory with the State-of-the-art Vivarium to carry out safety studies for regulatory submissions. Vipragen has deep scientific and research knowledge of the senior leadership team in areas such as General Toxicology, Reproductive Toxicology, Genetic Toxicology, Pharmacology, Analytical Chemistry, Bioanalytical and ADME. | Vipragen, a renowned Contract Research Organization (CRO), offers comprehensive services for global Pharmaceutical, Biopharmaceutical, Chemical, Nutraceutical and Medical Device companies. With over 12 years of experience, Vipragen Biosciences Private Limited is dedicated to delivering quality services. Under the leadership of Dr. Chandrashekaran Siddamadappa, Chairman and Managing Director, Vipragen has emerged as an Integrated Pre-clinical CRO, championing sustainability, integrity, safety and quality. Our state-of-the-art Vivarium holds Global certifications like OECD GLP, AAALAC and NABL, supported by multidisciplinary experts and equipped with 21CFR Part 11 compliance systems and processes. We ensure reliable data adhering to global standards with a focus on customer satisfaction. Our diverse portfolio includes Analytical, Toxicology and Chemistry services tailored to meet stringent regulatory submission requirements across the industries, ensuring compliance and transparency for clients across the industry spectrum.
Vettiva Saúde Animal
Vettiva Animal Health is a biotech startup focused exclusively on Research and Development (R&D) and commercialization of innovative pharmaceuticals derived from Medical Cannabis. It is also the first company to formalizeclinical development of cannabidiol-based veterinary candidate therapies with the Brazilian Ministry of Agriculture, Livestock, and Supply (MAPA).
UNESP
Sao Paulo State University and V-BioPharma, a brazilian CDMO
UI Pharmaceuticals
Contract pharmaceutical services include: Pre-formulation studies Formulation development (including lyophilization cycle development) Clinical supply manufacturing and testing Small scale commercial manufacturing and testing Analytical method development and validation Routine quality control analysis Stability studies Active pharmaceutical ingredient (API) and excipient release testing UI Pharmaceuticals is able to manufacture most dosage forms including sterile solutions and lyophilized powders; tablets; capsules; and non-sterile semisolids and liquids. | UI Pharmaceuticals stands as the longest-running, FDA-registered, university-affiliated pharmaceutical manufacturing facility in the United States. Since 1974, we have been a reliable partner in pharmaceutical product development, manufacturing, and testing, with services covering sterile solutions, lyophilized products, tablets, capsules, and non-sterile formats, including powders, semisolids, and liquids. Our experienced team brings deep industry knowledge and a commitment to the highest standards of quality, ensuring full compliance with cGMP regulations. With a steadfast dedication to client satisfaction, UI Pharmaceuticals supports innovation and excellence in contract pharmaceutical manufacturing and testing.
UDELA
Udelá is a regulatory consulting company. Udelá was created by a group of highly qualified professionals in the regulatory affairs field, with more than 15 years of experience, for medicines, medical devices, food, dietary supplements and cosmetics. Udelá is located in Mexico City, and has presence in Central and Latin America. Objectives – Provide technical and regulatory support, which accelerates the access of medicines, medical devices, food, dietary supplements and cosmetics on the market to improve the health of the population, through regulatory standard compliance and a build trust with regulatory agencies. – Bridge the knowledge gap of our clients in regulatory affairs to improve the communication with the regulatory agencies – Enhance processes of marketing authorization of medicines and medical devices (pre-marketing, registration and post marketing) to ease the access on the market and improve its maintenance – Active collaboration with our clients to generate better regulatory strategies to reduce timelines and optimize resources Services – Dossier compilation and evaluation o Medical Devices o New chemical entities/ New Molecules o Generics / Hybrids o Biotechnological products and Biosimilars o Vaccine o Biologics and blood derivative products – Design of regulatory strategies o Regulatory Due diligence o Feasibility studies for medicines and medical devices registration o Strategies for maintenance of existing and forthcoming products – Hosting & Testing services – Good manufacturing practices / License – Advertising – Translations – KOL feedback | At Udelá, we empower healthcare companies—whether local or international, emerging or established—to enter and expand in the complex markets of Mexico and Latin America. With over 5 years of experience, we specialize in regulatory intelligence, market entry strategies, and end-to-end support for pharmaceutical products, biotechnology, medical devices, cosmetics, food supplements, and more. We understand that navigating the ever-evolving regulatory frameworks of Latin American countries can be overwhelming if not approached strategically. That’s where we come in. Our multidisciplinary team of consultants combines in-depth knowledge of regional regulatory environments with strategic execution capabilities. We act with precision, pragmatism, and agility to deliver timely and compliant market access solutions. Our key services include: Regulatory and strategic consulting for healthcare products Legal representation and in-country regulatory agent services Warehousing and distribution infrastructure compliant with national regulations With headquarters in Mexico City and operations in Colombia, Brazil, Chile, Perú, Ecuador, Uruguay, Paraguay, Bolivia, Argentina and Central America, we offer both local expertise and regional reach. Whether you’re launching a generic, innovative, or biologic product—or seeking to expand your presence across LATAM—Udelá is your trusted partner in achieving regulatory clarity and commercial success. Where do you want to go next? Let’s go beyond, together.
TubeWriter
TubeWriter labeling systems is a full-feature instrument for printing directly at high-speed on the sides and caps of plastic, glass, and curved surfaces, including tubes, vials, slides, plates and custom labware. It is designed to address automating laboratory printing for assays, protocols and experiments. TubeWriter labeling withstands the harshest of lab conditions; resistant to chemical solvents and surviving long-term storage at -80C and liquid nitrogen. | TubeWriter is an automated labeling systems that prints directly on the surface of any labware eliminating the need for sticky labels. For laboratories that perform medium to high-throughput applications struggling with manual labeling or paper labels, the TubeWriter prints directly on the sides and caps of tubes, vials, plates and unique labware. TubeWriter prints text, images, and barcodes using UV-curable ink that withstands extreme lab conditions, most harsh chemicals and long-term storage at -80C and liquid nitrogen.
Transpharm Preclinical Solutions
TransPharm is an AAALAC accredited facility, “#001301” and registered with the Office of Laboratory Animal Welfare (OLAW), Assurance #A4747-01. Our only focus is Infectious Disease research, and I believe no one can compete with us regarding passion for this research or match our competitive rate. The company is housed in an interconnected 8,300-sq. ft. complex of buildings including a 3,100-sq. ft. vivarium with an attending 230 sq. ft. surgical suite. The vivarium is split with negative and positive pressured areas equipped with bioBubble® clean rooms. The facility is designed to handle all BSL II Applications. General laboratory work is conducted in a 1,700-sq. ft. wet lab equipped to handle all microbiological procedures and analyses. This work area includes biological containment hoods, sterile workstations, chemical use hoods, and general lab work benches. The entire facility is backed up by a 90,000-watt generator to avoid any catastrophic loss of data. The administrative area includes 1,220 sq. ft. of office space complete with video-link conference room. Our lab is spearheaded by Marci Peek, acting as the Chief Scientific Officer. We have a staff of 6 employees, with most of them being AALAS certified and one being a Board-Certified Veterinary Technician.